OUR JOURNEY

Advancing Continuous Oral Delivery

From patented engineering to clinical studies and strategic partnerships, Contoral is building the evidence and capabilities to bring Continuous Oral Delivery to patients.

Traction

Strong early progress. A clear path toward clinical validation and commercialization.

S$400K

EnterpriseSG POC funding secured

100+

Dentists registered product interest

Global IP Foundation

Licensed portfolio plus Contoral patent filed

Clinical Development Underway

User and clinician studies have shaped the design; feasibility studies began in 2026

The Path Ahead

2026–2027 Clinical Validation

Executing rigorous clinical studies to confirm the safety and efficacy of our Continuous Oral Delivery platform.

2027–2028 Manufacturing & Regulatory Readiness

Scaling industrial production while securing necessary regulatory approvals for global healthcare market entry.

2028 Commercial Launch

Introducing our first dental appliance products to specialized clinicians and their patients globally.

Beyond Launch Platform Expansion

Broadening the Continuous Oral Delivery application to encompass a wider range of therapeutic categories and patient needs.

Advancing through Partnership

Continuous Oral Delivery is being advanced through collaboration across clinical care, research, engineering and industry.

Clinical

Research & Engineering

Industry

Innovation & Funding

Enterprise Singapore

The Next Chapter

We’re moving from product development into clinical validation—building toward commercial launch while continuing to expand the possibilities of Continuous Oral Delivery.